Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil and memantine in moderate to severe Alzheimer's disease
2007-001172-36Phase 4Completed
- Sponsor
- King's College London
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of donepezil and memantine in Alzheimer's disease (AD) (4 arms), sponsored by King's College London. Primary endpoint: Cognitive function. Started Aug 2007; status: completed.
02
Drugs
donepezilmemantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2007-001172-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001172-36.